Global research trends of tumor microenvironment in non-small cell lung cancer with epidermal growth factor receptor mutation: a bibliometric analysis from 2014 to 2023
Effective drug treatment of advanced NSCLC with EGFR mutations after failure of first-line chemotherapy is one of the hotspots, in which the efficacy of immune checkpoint inhibitors may be the direction of the current and future studies that need to find a breakthrough.
Authors
- Linyou Zhang (ORCID: https://orcid.org/0000-0002-9946-4213)
- Fei Wang (ORCID: https://orcid.org/0000-0003-3320-677X)
- Xiaoyan Chang (ORCID: https://orcid.org/0000-0003-0963-642X)
- Chenghao Wang (ORCID: https://orcid.org/0000-0003-0641-6405)
Institutions
- Harbin Medical University (CN)
- Second Affiliated Hospital of Harbin Medical University (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-03-20
- DOI
- https://doi.org/10.3389/fimmu.2025.1555216
- Citations
- 1
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 1.05